FeaturesSignalPricingFounders
Log inGet started free
MP

Michael Penington

Angel InvestorActive

Mr. Urs Wietlisbach is a Co-Founder of Partners Group where he serves as a Member of the Board of Directors, and Chairman of the Client Oversight Committee at Partners Group. He also is a Co-Founder of Property One Partners and serves as a Member of the Advisory Board at both Property One Partners and Swiss Startup Capital. He is the Founder and serves as President of the Wietlisbach Foundation. He is a Co-Founder and serves as the Chairman of the Board of directors of Blue Earth Capital. He was initially responsible for the firm's partnership investment activities and instrumental in building Partners Group's private equity funds portfolio and a global industry network. Later, he also focused on business development responsibilities, first in Europe, and subsequently in the USA and the Asia-Pacific region. Prior to founding Partners Group, he was an executive director at Goldman Sachs & Co. where, after assignments in London and New York, he was appointed head of the firm's institutional clients business in Switzerland. Previously, he was a relationship manager for multinational corporate clients at Credit Suisse in New York and Zurich. He holds a master's degree in business administration from the University of St. Gallen (HSG).

SwitzerlandFounded 2022linkedin.com
22
Investments
0
Exits
AUM
0.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Michael Penington.

Get started free

Investment Thesis & Strategy

As an angel investor, Michael Penington invests in various stages across a broad range of industries. He likely seeks promising early-stage companies with high growth potential.

Investment Activity

Deals per year over the last 7 years

2
2013
1
2014
1
2015
0
2016
3
2017
3
2018
2
2019

Portfolio Companies

Selected investments from their portfolio of 22 companies

S
Sensiia
Healthcare · Seed, 2019
Active
L
LettUs Grow
Cleantech · Seed, 2019
Active
B
Base4
Other · Seed, 2018
Active
V
Verdel Instruments
Other · Seed, 2018
Active
C
Caristo Diagnostics
Healthcare · Seed, 2018
Active
M
MicrofluidX
Biotech · Seed, 2017
Active
C
Closed Loop Medicine
Biotech · Seed, 2017
Active
W
Wayland Additive
Other · Seed, 2017
Active
A
Azellon Cell Therapeutics
Biotech · Seed, 2015
Active
C
Crysalin
Biotech · Seed, 2014
Active
O
OxSonics Therapeutics
Biotech · Seed, 2013
Active
O
Oxford Space Systems
Other · Seed, 2013
Active

Frequently Asked Questions

Michael Penington focuses on Pre-seed, Seed stage investments.

Related Investors